Literature DB >> 16926433

The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor.

Shaoguang Wu1, Jai Shin, Guangming Zhang, Mitchell Cohen, Augusto Franco, Cynthia L Sears.   

Abstract

The Bacteroides fragilis toxin (BFT) is the only known virulence factor of enterotoxigenic B. fragilis. BFT has previously been shown to act, at least in part, through cleavage of the intercellular adhesion protein E-cadherin. A specific cellular receptor for BFT has not been identified. The goal of this study was to determine if the initial interaction of BFT with intestinal epithelial cells was consistent with binding to a specific cellular receptor. Purified BFT was labeled with a fluorophore or iodide to assess specific cellular binding and the properties of BFT cellular binding. BFT binds specifically to intestinal epithelial cell lines in vitro in a polarized manner. However, specific binding occurs only at 37 degrees C and requires BFT metalloprotease activity. The BFT receptor is predicted to be a membrane protein other than E-cadherin or a known protease-activated receptor (PAR1 to PAR4). BFT binding is resistant to acid washing, suggesting an irreversible interaction. Sugar or lipid residues do not appear to be involved in the mechanism of BFT cellular binding, but binding is sensitive to membrane cholesterol depletion. We conclude that intestinal epithelial cells in vitro possess a specific membrane BFT receptor that is distinct from E-cadherin. The data favor a model in which the metalloprotease domain of BFT processes its receptor protein, initiating cellular signal transduction that mediates the biological activity of BFT. However, activation of recognized protease-activated receptors does not mimic or block BFT biological activity or binding, suggesting that additional protease-activated receptors on intestinal epithelial cells remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926433      PMCID: PMC1594844          DOI: 10.1128/IAI.00060-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Mutation of the zinc-binding metalloprotease motif affects Bacteroides fragilis toxin activity but does not affect propeptide processing.

Authors:  Augusto A Franco; Simy L Buckwold; Jai W Shin; Miguel Ascon; Cynthia L Sears
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 2.  Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.

Authors:  Kathryn Turton; John A Chaddock; K Ravi Acharya
Journal:  Trends Biochem Sci       Date:  2002-11       Impact factor: 13.807

3.  Diversity of the metalloprotease toxin produced by enterotoxigenic Bacteroides fragilis.

Authors:  Shaoguang Wu; Lawrence A Dreyfus; Art O Tzianabos; Chika Hayashi; Cynthia L Sears
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway.

Authors:  Shaoguang Wu; Jan Powell; Nes Mathioudakis; Sheryl Kane; Ellen Fernandez; Cynthia L Sears
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  The Bacteroides fragilis pathogenicity island is contained in a putative novel conjugative transposon.

Authors:  Augusto A Franco
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

6.  Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation.

Authors:  Shaoguang Wu; Patrice J Morin; Djik Maouyo; Cynthia L Sears
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

Review 7.  Lipid rafts in epithelial brush borders: atypical membrane microdomains with specialized functions.

Authors:  E Michael Danielsen; Gert H Hansen
Journal:  Biochim Biophys Acta       Date:  2003-10-31

8.  Modulation of bft expression by the Bacteroides fragilis pathogenicity island and its flanking region.

Authors:  Augusto A Franco; Rodney K Cheng; Alan Goodman; Cynthia L Sears
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

Review 9.  Presynaptic receptor arrays for clostridial neurotoxins.

Authors:  Cesare Montecucco; Ornella Rossetto; Giampietro Schiavo
Journal:  Trends Microbiol       Date:  2004-10       Impact factor: 17.079

10.  Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2.

Authors:  D Darmoul; J C Marie; H Devaud; V Gratio; M Laburthe
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

View more
  44 in total

1.  Modelling spatially regulated beta-catenin dynamics and invasion in intestinal crypts.

Authors:  Philip J Murray; Jun-Won Kang; Gary R Mirams; Sung-Young Shin; Helen M Byrne; Philip K Maini; Kwang-Hyun Cho
Journal:  Biophys J       Date:  2010-08-04       Impact factor: 4.033

Review 2.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

Review 3.  A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects.

Authors:  Harold Tjalsma; Annemarie Boleij; Julian R Marchesi; Bas E Dutilh
Journal:  Nat Rev Microbiol       Date:  2012-06-25       Impact factor: 60.633

4.  Epigenetic Changes Induced by Bacteroides fragilis Toxin.

Authors:  Jawara Allen; Stephanie Hao; Cynthia L Sears; Winston Timp
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

5.  A Two-Component System Regulates Bacteroides fragilis Toxin to Maintain Intestinal Homeostasis and Prevent Lethal Disease.

Authors:  Aaron L Hecht; Benjamin W Casterline; Vivian M Choi; Juliane Bubeck Wardenburg
Journal:  Cell Host Microbe       Date:  2017-09-21       Impact factor: 21.023

6.  Impact of prior antibiotic use on the efficacy of nivolumab for non-small cell lung cancer.

Authors:  Taiki Hakozaki; Yusuke Okuma; Miwako Omori; Yukio Hosomi
Journal:  Oncol Lett       Date:  2019-01-08       Impact factor: 2.967

7.  Peptide Sequence Region That is Essential for the Interactions of the Enterotoxigenic Bacteroides fragilis Metalloproteinase II with E-cadherin.

Authors:  Sergey A Shiryaev; Albert G Remacle; Piotr Cieplak; Alex Y Strongin
Journal:  J Proteolysis       Date:  2014-12-22

8.  Molecular modeling and dynamics studies of purine nucleoside phosphorylase from Bacteroides fragilis.

Authors:  Ivani Pauli; Luis Fernando Saraiva Macedo Timmers; Rafael Andrade Caceres; Luiz Augusto Basso; Diógenes Santiago Santos; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2009-01-27       Impact factor: 1.810

9.  Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells.

Authors:  Liam Chung; Erik Thiele Orberg; Abby L Geis; June L Chan; Kai Fu; Christina E DeStefano Shields; Christine M Dejea; Payam Fathi; Jie Chen; Benjamin B Finard; Ada J Tam; Florencia McAllister; Hongni Fan; Xinqun Wu; Sudipto Ganguly; Andriana Lebid; Paul Metz; Sara W Van Meerbeke; David L Huso; Elizabeth C Wick; Drew M Pardoll; Fengyi Wan; Shaoguang Wu; Cynthia L Sears; Franck Housseau
Journal:  Cell Host Microbe       Date:  2018-02-01       Impact factor: 21.023

10.  Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice.

Authors:  Ki-Jong Rhee; Shaoguang Wu; Xinqun Wu; David L Huso; Baktiar Karim; Augusto A Franco; Shervin Rabizadeh; Jonathan E Golub; Lauren E Mathews; Jai Shin; R Balfour Sartor; Douglas Golenbock; Abdel R Hamad; Christine M Gan; Franck Housseau; Cynthia L Sears
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.